EDAP TMS SA announced today that the FDA granted 510(k) clearance for new workflows for its ultrasound technology.

EDAP TMS ( ($EDAP) ) has shared an update. On November 20, 2025, EDAP TMS announced that it received FDA 510(k) clearance for enhancements to its ...

A multicenter clinical study in Austria has shown that a new, highly precise ultrasound approach can successfully target and treat early prostate cancer while preserving patients' quality of life.

AUSTIN, Texas, November 20, 2025 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) ...

Focused ultrasound (HIFU) offers safe, effective treatment: Study: Krems, Austria Thursday, November 20, 2025, 11:00 Hrs [IST] A multicenter cl ...

Defense Secretary Lloyd Austin's medical issues last December put the spotlight on fighting prostate cancer while reducing the risk of side effects and complications. A trial here on a less invasive ...

Dublin, Aug. 04, 2020 (GLOBE NEWSWIRE) -- The "High Intensity Focused Ultrasound (HIFU) Market, Forecast by Application (Prostate Cancer, Neurological Disorder, Cosmetic Medicine, Uterine Fibroids), ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "High Intensity Focused Ultrasound (HIFU) - Company Profile, Recent Development and Product Analysis" company profile to ...

Toosonix A/S has launched two trials as it moves to gather data enabling its high-intensity focused ultrasound (HIFU) device to get approval for use in clinical dermatology indications. The company ...

High-Intensity Focused Ultrasound (HIFU) represents a transformative non‐invasive modality in modern medicine. By concentrating ultrasonic energy to a precise focal point, HIFU achieves targeted ...

A study from Karl Landsteiner University of Health Sciences demonstrates that treatment with focused ultrasound (HIFU) effectively controls prostate cancer and maintains patients’ quality of ...